Illumina Inc (ILMN) 172.80 $ILMN
Illumina (ILMN) in Focus: Stock Adds 6.6% in Session
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 7:00AM CST
Illumina (ILMN) was a big mover last session with its shares rising roughly 7% on the day.
ILMN: 172.80 (+2.69)
Facebook, Apple, Gilead Honchos Lead Insider Deals
at Investor's Business Daily - Fri Nov 13, 5:21PM CST
An early investor in Facebook (FB) continued to sell shares of the social media leader this past week as the stock peaked, while Apple's (AAPL) chief sold another chunk of the iPhone maker's stock, which slumped. Facebook Director Marc Andreessen,...
FSLR: 52.80 (-1.38), SWKS: 77.19 (+1.91), GILD: 104.30 (+0.49), SUNE: 3.16 (-1.40), FB: 104.77 (+0.73), MRK: 53.66 (-0.04), STZ: 136.95 (+1.69), ILMN: 172.80 (+2.69), AAPL: 113.61 (-0.57)
SmarTrend Watching for Potential Pullback in Shares of Illumina After 6.60% Gain
Comtex SmarTrend(R) - Fri Nov 13, 4:16PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $161.79 to a high of $168.24. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $158.67 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 172.80 (+2.69)
Watch for Illumina to Potentially Pullback After Gaining 6.60% Yesterday
Comtex SmarTrend(R) - Fri Nov 13, 4:16PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $161.79 to a high of $168.24. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $158.67 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 172.80 (+2.69)
Illumina (ILMN) Set to Enter the Coveted S&P 500, Stock Up
Zacks Equity Research - Zacks Investment Research - Fri Nov 13, 1:50PM CST
Illumina Inc. (ILMN) has been selected by S&P Dow Jones Indices to join the prestigious Standard & Poor's (S&P) 500 Index.
HSKA: 35.11 (+0.12), ILMN: 172.80 (+2.69), ANIK: 41.64 (-0.19)
Illumina (ILMN) Stock Advances Ahead of Joining S&P 500
at The Street - Fri Nov 13, 12:24PM CST
Illumina (ILMN) stock is increasing in midday trading on Friday, after the S&P Dow Jones Indices announced it will join the S&P 500 Index next week.
ILMN: 172.80 (+2.69)
Downtrend Call Working As Illumina Stock Falls 14.7% (ILMN)
Comtex SmarTrend(R) - Fri Nov 13, 10:57AM CST
SmarTrend identified a Downtrend for Illumina (NASDAQ:ILMN) on September 23rd, 2015 at $192.13. In approximately 2 months, Illumina has returned 14.71% as of today's recent price of $163.87.
ILMN: 172.80 (+2.69)
Illumina Set to Join the S&P 500
PR Newswire - Thu Nov 12, 5:44PM CST
Illumina Inc. (NASD:ILMN) will replace Sigma-Aldrich Corp. (NASD:SIAL) in the S&P 500 after the close of trading on Wednesday, November 18. Merck KGaA is acquiring Sigma-Aldrich in a deal expected to be completed on or about that date pending final conditions.
SIAL: 139.85 (+0.04), ILMN: 172.80 (+2.69), MHFI: 95.44 (+0.14)
Why Pacific Biosciences of California Jumped 30% in October
Brian Feroldi, The Motley Fool - Motley Fool - Thu Nov 12, 8:18AM CST
What: Shareholders in Pacific Biosciences of California , a provider of gene sequencing technology, had a very prosperous October as the company released some good news during the month that caused its shares to skyrocket more than 30% higher. ...
PACB: 8.07 (+0.30), ILMN: 172.80 (+2.69)
Mohr Davidow Ventures Focuses on Closing the Gender Gap in Technology With a Private Screening of CodeGirl and Panel Discussion
Marketwired - Wed Nov 11, 7:01AM CST
Mohr Davidow Ventures, one of Silicon Valley's leading venture firms specializing in early-stage technology-based startups, today announced that it will be hosting a private screening of CodeGirl, the latest documentary from Director Lesley Chilcott (executive producer of An Inconvenient Truth and Waiting for Superman). After the film -- which follows ten teams of girls as they compete in Technovation, an entrepreneurship and coding competition -- Katherine Barr, general partner at Mohr Davidow Ventures, will host a panel discussion with some of Silicon Valley's most accomplished women about how to close the gender gap that leaves women under-represented in the world of technology and science.
PACB: 8.07 (+0.30), PFPT: 72.59 (+1.38), P: 12.48 (-0.94), ADMS: 15.24 (-0.05), SFLY: 44.48 (+0.34), FUEL: 3.22 (-0.23), ILMN: 172.80 (+2.69), RMBS: 10.78 (+0.14), CA: 26.82 (-0.05), BRCD: 10.09 (+0.02)
Global Biochips Markets 2015-2021 - Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecasts
M2 - Wed Nov 11, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/9zxf5c/global_biochips) has announced the addition of the "Global Biochips Markets by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering. The global market for Biochips is expected to grow at an annual growth rate (CAGR) of approximately 18% (2015-2021) A Biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that can perform hundreds or thousands of simultaneous biochemical reactions in order to achieve higher throughput and speed. Biochips help researchers to quickly see large number of biological analytics and are used in a range of research applications within the biotechnology sector, including pharmaceuticals, proteomics and genomics. Biochips are also used in analysis of organic molecules associated with living organisms and help in identifying gene sequences, airborne toxins, environmental pollutants and other biochemical constituents. Although, biochips have been developed and commercialized in mid eighties but the market has transformed in the starting of last decade. Presently, the biochips market is undergoing rapid expansion with the discovery of new applications and the development of existing technologies. The key driving forces for the market of biochips are: growth in personalized medicine market, increase in government spending/ private investment in healthcare budgets and R&D respectively, rising case of lifestyle related diseases and so on. Various factors such as less accuracy of biochips that may lead to wrong analysis, low rate of translation of discoveries in drugs, medical devices and protein biomarkers, low acceptance due to high cost and availability of alternative technologies are restraining the growth of biochips market. The key players in global biochips market are Agilent technologies Affymetric Inc, Gene system Inc, Agendia BV Inc, Customarray inc, Digital genomics inc, Bio chain institute Inc, Biomerieux SA , Bio-rad laboratories inc, Cepheid Inc, Caliper life sciences Inc, Cybrdi Inc, EMD Millipore, Elim Biopharmaceuticals, Falcon Genomics, Genalyte and so on. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiling - Affymetrix inc - Agendia BV inc - Agilent technologies - Bio chain institute Inc - Biomerieux SA - Bio-rad laboratories inc - Caliper life sciences inc - Cepheid Inc - Customarray inc - Cybrdi inc - Digital genomics inc - Elim Biopharmaceuticals - EMD Millipore - Falcon Genomics - Fluidigm corp - Gamida for life group - Genalyte - Gene system inc - Illumina Inc - Imgenex - ISU ABXIS co ltd - Life technologies corp - Origene technologies Inc - Oxford gene technology - Perkinelmer inc - Predictive biosciences - Quantalife inc - Roche nimblegen inc - Sequenom - Sigma aldrich corp - Wafergen biosystems inc For more information visit http://www.researchandmarkets.com/research/9z...l_biochips
SQNM: 1.64 (-0.03), FLDM: 9.84 (-0.31), CPHD: 35.30 (+0.21), ILMN: 172.85 (+2.74), AFFX: 8.99 (+0.07)
TrovaGene Rallies despite Wider-than-Expected Q3 Loss
Zacks Equity Research - Zacks Investment Research - Tue Nov 10, 8:50AM CST
TrovaGene Inc (TROV) reported adjusted loss of 37 cents per share in the third quarter of 2015, wider than the Zacks Consensus Estimate of a loss of 28 cents.
TROV: 5.47 (unch), ILMN: 172.85 (+2.74), BXLT: 34.15 (-0.33), ANIK: 41.64 (-0.19)
Global Next Generation Sequencing Informatics/Software Market 2015-2020 - Market to Reach $868.6 Million by 2020
GlobeNewswire - Fri Nov 06, 2:48PM CST
Research and Markets (http://www.researchandmarkets.com/research/j2w476/global_next) has announced the addition of the "Global Next Generation Sequencing Informatics/Software Market Outlook: 2015-2020" report to their offering.
ILMN: 172.85 (+2.74), EMC: 25.17 (-0.10), QGEN: 26.31 (+0.68), PKI: 51.23 (+0.22)
Illumina Shares Down 19.5% Since SmarTrend's Sell Call (ILMN)
Comtex SmarTrend(R) - Fri Nov 06, 10:19AM CST
SmarTrend identified a Downtrend for Illumina (NASDAQ:ILMN) on September 23rd, 2015 at $192.13. In approximately 1 month, Illumina has returned 19.46% as of today's recent price of $154.74.
ILMN: 172.90 (+2.79)
Covered Call Alerts For FireEye, Chipotle Mexican Grill, American Airlines, Delta Airlines and Illumina Released By InvestorsObserver
PR Newswire - Wed Nov 04, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for FEYE, CMG, AAL, DAL and ILMN.
FEYE: 21.59 (-0.88), DAL: 47.88 (-0.05), CMG: 582.12 (-6.62), ILMN: 172.90 (+2.79), AAL: 42.12 (-0.71)
Illumina Set to Possibly Pullback After Yesterday's Rally of 2.70%
Comtex SmarTrend(R) - Tue Nov 03, 4:08PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $146.82 to a high of $155.31. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $149.22 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 172.90 (+2.79)
Don't Allow A Healthy Winner To Turn Into A Loser
at Investor's Business Daily - Tue Nov 03, 3:41PM CST
In order to succeed in investing, you can't just shoot from the hip. Instead, some key rules must be followed. When a breakout that had been working well suddenly starts to fizzle, don't be a deer in the headlights. You need to take action or else...
ILMN: 172.90 (+2.79)
Illumina Announces New $250 Million Share Repurchase Authorization
Business Wire - Mon Nov 02, 5:30AM CST
Illumina (Nasdaq:ILMN) today announced that its Board of Directors has authorized the company to repurchase, on a discretionary basis, up to $250 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The company also announced the completion of the existing discretionary authorization of $96 million that was repurchased since the company reported earnings on October 20th.
ILMN: 172.90 (+2.79)
Illumina (ILMN) in Focus: Stock Adds 6.6% in Session
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 7:00AM CST
Illumina (ILMN) was a big mover last session with its shares rising roughly 7% on the day.
ILMN: 172.80 (+2.69)
Facebook, Apple, Gilead Honchos Lead Insider Deals
at Investor's Business Daily - Fri Nov 13, 5:21PM CST
An early investor in Facebook (FB) continued to sell shares of the social media leader this past week as the stock peaked, while Apple's (AAPL) chief sold another chunk of the iPhone maker's stock, which slumped. Facebook Director Marc Andreessen,...
FSLR: 52.80 (-1.38), SWKS: 77.19 (+1.91), GILD: 104.30 (+0.49), SUNE: 3.16 (-1.40), FB: 104.77 (+0.73), MRK: 53.66 (-0.04), STZ: 136.95 (+1.69), ILMN: 172.80 (+2.69), AAPL: 113.61 (-0.57)
SmarTrend Watching for Potential Pullback in Shares of Illumina After 6.60% Gain
Comtex SmarTrend(R) - Fri Nov 13, 4:16PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $161.79 to a high of $168.24. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $158.67 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 172.80 (+2.69)
Watch for Illumina to Potentially Pullback After Gaining 6.60% Yesterday
Comtex SmarTrend(R) - Fri Nov 13, 4:16PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $161.79 to a high of $168.24. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $158.67 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 172.80 (+2.69)
Illumina (ILMN) Set to Enter the Coveted S&P 500, Stock Up
Zacks Equity Research - Zacks Investment Research - Fri Nov 13, 1:50PM CST
Illumina Inc. (ILMN) has been selected by S&P Dow Jones Indices to join the prestigious Standard & Poor's (S&P) 500 Index.
HSKA: 35.11 (+0.12), ILMN: 172.80 (+2.69), ANIK: 41.64 (-0.19)
Illumina (ILMN) Stock Advances Ahead of Joining S&P 500
at The Street - Fri Nov 13, 12:24PM CST
Illumina (ILMN) stock is increasing in midday trading on Friday, after the S&P Dow Jones Indices announced it will join the S&P 500 Index next week.
ILMN: 172.80 (+2.69)
Downtrend Call Working As Illumina Stock Falls 14.7% (ILMN)
Comtex SmarTrend(R) - Fri Nov 13, 10:57AM CST
SmarTrend identified a Downtrend for Illumina (NASDAQ:ILMN) on September 23rd, 2015 at $192.13. In approximately 2 months, Illumina has returned 14.71% as of today's recent price of $163.87.
ILMN: 172.80 (+2.69)
Illumina Set to Join the S&P 500
PR Newswire - Thu Nov 12, 5:44PM CST
Illumina Inc. (NASD:ILMN) will replace Sigma-Aldrich Corp. (NASD:SIAL) in the S&P 500 after the close of trading on Wednesday, November 18. Merck KGaA is acquiring Sigma-Aldrich in a deal expected to be completed on or about that date pending final conditions.
SIAL: 139.85 (+0.04), ILMN: 172.80 (+2.69), MHFI: 95.44 (+0.14)
Why Pacific Biosciences of California Jumped 30% in October
Brian Feroldi, The Motley Fool - Motley Fool - Thu Nov 12, 8:18AM CST
What: Shareholders in Pacific Biosciences of California , a provider of gene sequencing technology, had a very prosperous October as the company released some good news during the month that caused its shares to skyrocket more than 30% higher. ...
PACB: 8.07 (+0.30), ILMN: 172.80 (+2.69)
Mohr Davidow Ventures Focuses on Closing the Gender Gap in Technology With a Private Screening of CodeGirl and Panel Discussion
Marketwired - Wed Nov 11, 7:01AM CST
Mohr Davidow Ventures, one of Silicon Valley's leading venture firms specializing in early-stage technology-based startups, today announced that it will be hosting a private screening of CodeGirl, the latest documentary from Director Lesley Chilcott (executive producer of An Inconvenient Truth and Waiting for Superman). After the film -- which follows ten teams of girls as they compete in Technovation, an entrepreneurship and coding competition -- Katherine Barr, general partner at Mohr Davidow Ventures, will host a panel discussion with some of Silicon Valley's most accomplished women about how to close the gender gap that leaves women under-represented in the world of technology and science.
PACB: 8.07 (+0.30), PFPT: 72.59 (+1.38), P: 12.48 (-0.94), ADMS: 15.24 (-0.05), SFLY: 44.48 (+0.34), FUEL: 3.22 (-0.23), ILMN: 172.80 (+2.69), RMBS: 10.78 (+0.14), CA: 26.82 (-0.05), BRCD: 10.09 (+0.02)
Global Biochips Markets 2015-2021 - Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecasts
M2 - Wed Nov 11, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/9zxf5c/global_biochips) has announced the addition of the "Global Biochips Markets by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering. The global market for Biochips is expected to grow at an annual growth rate (CAGR) of approximately 18% (2015-2021) A Biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that can perform hundreds or thousands of simultaneous biochemical reactions in order to achieve higher throughput and speed. Biochips help researchers to quickly see large number of biological analytics and are used in a range of research applications within the biotechnology sector, including pharmaceuticals, proteomics and genomics. Biochips are also used in analysis of organic molecules associated with living organisms and help in identifying gene sequences, airborne toxins, environmental pollutants and other biochemical constituents. Although, biochips have been developed and commercialized in mid eighties but the market has transformed in the starting of last decade. Presently, the biochips market is undergoing rapid expansion with the discovery of new applications and the development of existing technologies. The key driving forces for the market of biochips are: growth in personalized medicine market, increase in government spending/ private investment in healthcare budgets and R&D respectively, rising case of lifestyle related diseases and so on. Various factors such as less accuracy of biochips that may lead to wrong analysis, low rate of translation of discoveries in drugs, medical devices and protein biomarkers, low acceptance due to high cost and availability of alternative technologies are restraining the growth of biochips market. The key players in global biochips market are Agilent technologies Affymetric Inc, Gene system Inc, Agendia BV Inc, Customarray inc, Digital genomics inc, Bio chain institute Inc, Biomerieux SA , Bio-rad laboratories inc, Cepheid Inc, Caliper life sciences Inc, Cybrdi Inc, EMD Millipore, Elim Biopharmaceuticals, Falcon Genomics, Genalyte and so on. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiling - Affymetrix inc - Agendia BV inc - Agilent technologies - Bio chain institute Inc - Biomerieux SA - Bio-rad laboratories inc - Caliper life sciences inc - Cepheid Inc - Customarray inc - Cybrdi inc - Digital genomics inc - Elim Biopharmaceuticals - EMD Millipore - Falcon Genomics - Fluidigm corp - Gamida for life group - Genalyte - Gene system inc - Illumina Inc - Imgenex - ISU ABXIS co ltd - Life technologies corp - Origene technologies Inc - Oxford gene technology - Perkinelmer inc - Predictive biosciences - Quantalife inc - Roche nimblegen inc - Sequenom - Sigma aldrich corp - Wafergen biosystems inc For more information visit http://www.researchandmarkets.com/research/9z...l_biochips
SQNM: 1.64 (-0.03), FLDM: 9.84 (-0.31), CPHD: 35.30 (+0.21), ILMN: 172.85 (+2.74), AFFX: 8.99 (+0.07)
TrovaGene Rallies despite Wider-than-Expected Q3 Loss
Zacks Equity Research - Zacks Investment Research - Tue Nov 10, 8:50AM CST
TrovaGene Inc (TROV) reported adjusted loss of 37 cents per share in the third quarter of 2015, wider than the Zacks Consensus Estimate of a loss of 28 cents.
TROV: 5.47 (unch), ILMN: 172.85 (+2.74), BXLT: 34.15 (-0.33), ANIK: 41.64 (-0.19)
Global Next Generation Sequencing Informatics/Software Market 2015-2020 - Market to Reach $868.6 Million by 2020
GlobeNewswire - Fri Nov 06, 2:48PM CST
Research and Markets (http://www.researchandmarkets.com/research/j2w476/global_next) has announced the addition of the "Global Next Generation Sequencing Informatics/Software Market Outlook: 2015-2020" report to their offering.
ILMN: 172.85 (+2.74), EMC: 25.17 (-0.10), QGEN: 26.31 (+0.68), PKI: 51.23 (+0.22)
Illumina Shares Down 19.5% Since SmarTrend's Sell Call (ILMN)
Comtex SmarTrend(R) - Fri Nov 06, 10:19AM CST
SmarTrend identified a Downtrend for Illumina (NASDAQ:ILMN) on September 23rd, 2015 at $192.13. In approximately 1 month, Illumina has returned 19.46% as of today's recent price of $154.74.
ILMN: 172.90 (+2.79)
Covered Call Alerts For FireEye, Chipotle Mexican Grill, American Airlines, Delta Airlines and Illumina Released By InvestorsObserver
PR Newswire - Wed Nov 04, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for FEYE, CMG, AAL, DAL and ILMN.
FEYE: 21.59 (-0.88), DAL: 47.88 (-0.05), CMG: 582.12 (-6.62), ILMN: 172.90 (+2.79), AAL: 42.12 (-0.71)
Illumina Set to Possibly Pullback After Yesterday's Rally of 2.70%
Comtex SmarTrend(R) - Tue Nov 03, 4:08PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $146.82 to a high of $155.31. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $149.22 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ILMN: 172.90 (+2.79)
Don't Allow A Healthy Winner To Turn Into A Loser
at Investor's Business Daily - Tue Nov 03, 3:41PM CST
In order to succeed in investing, you can't just shoot from the hip. Instead, some key rules must be followed. When a breakout that had been working well suddenly starts to fizzle, don't be a deer in the headlights. You need to take action or else...
ILMN: 172.90 (+2.79)
Illumina Announces New $250 Million Share Repurchase Authorization
Business Wire - Mon Nov 02, 5:30AM CST
Illumina (Nasdaq:ILMN) today announced that its Board of Directors has authorized the company to repurchase, on a discretionary basis, up to $250 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The company also announced the completion of the existing discretionary authorization of $96 million that was repurchased since the company reported earnings on October 20th.
ILMN: 172.90 (+2.79)
